OpenAI sued in US over alleged role in fatal epilepsy medication withdrawal
( October 27, 2026, 23:00 GMT | Official Statement) -- MLex Summary: The parents of Bowen Wan, a 31-year-old software engineer, allege that OpenAI's ChatGPT guided their daughter through an unsupervised withdrawal from epilepsy medication, encouraged her to conceal it from doctors and dismissed warning signs before her death. They assert several causes of action against OpenAI entities and CEO Sam Altman, seeking damages and court-ordered restrictions on medical advice.See complaint attached: ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.